Newsroom | 4985 results

ZHUZHOU, China & BOSTON--(BUSINESS WIRE)--Zonsen PepLib Biotech Inc. (“PepLib”) today announced that it has entered into a worldwide license agreement with Novartis for an undisclosed peptide-based asset in the field of radioligand therapies (RLTs). Under the agreement, Novartis has obtained an exclusive worldwide license and will be responsible for the development and commercialization activities for the asset. The asset has been developed internally by PepLib to date. Through this transaction...

TORONTO, Ontario & HALIFAX, Nova Scotia & ST. JOHN'S, Newfoundland and Labrador--(BUSINESS WIRE)--Today, Medventions, Canada’s leading medical technology (medtech) innovation and entrepreneurship program, launched a pilot program in Newfoundland and Labrador, in partnership with Newfoundland and Labrador (NL) Health Services and the Nova Scotia Health Innovation Hub. This pilot program marks the third Medventions site across Canada, further expanding the program’s national reach. Founded in 201...

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced a landmark clinical research collaboration to evaluate precision radiomodulation therapy for treatment-resistant depression (TRD) using the ZAP-X® Gyroscopic Radiosurgery® platform*. The study titled the Precision Radiomodulation Therapy Project for Depression is jointly led by Beijing Anding Hospital of Capital Medical University, Chinese PLA General Hospital...

LOVELAND, Colo.--(BUSINESS WIRE)--Antech™ launches next-generation AI-powered diagnostic innovations to advance veterinary clinical decision-making at VMX 2026...

IRVING, Texas--(BUSINESS WIRE)--The expanded collaboration enhances AdventHealth’s access to Vizient’s robust data and digital offerings....

IRVING, Texas--(BUSINESS WIRE)--This program celebrates those who drive innovation, efficiency and excellence across the healthcare industry....

PLANO, Texas--(BUSINESS WIRE)--CIVIE, a leading provider of healthcare and radiology operations solutions, today announced that the CIVIE platform has earned certified status from HITRUST for cybersecurity and information protection. The HITRUST e1 Certification verifies that the CIVIE ecosystem, comprised of a Radiology Information System (RIS), Picture Archiving and Communication System (PACS), AI-powered Radiology Dictation Solution (ASR), Revenue Cycle Management (RCM), and Vendor Neutral A...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced preliminary, unaudited revenue, net cash burn, and cash and cash equivalents for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Preliminary, Unaudited Financial Results Preliminary, unaudited revenue for the fourth qua...

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”, “the company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced that it expects to report revenue growth for the fourth quarter ended December 31, 2025 of at least 17% year over year. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “We enter 2026 with strong momentum and...

BERLIN & NAPLES, Fla.--(BUSINESS WIRE)--Bayer, a leading company in key areas of radiology and cardiology, and Attralus, Inc. (Attralus), a clinical stage biopharmaceutical company focused on developing medicines and diagnostics for systemic amyloidosis, today announced that the companies have entered into definitive agreements for Bayer to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m), two investigational molecular imaging agents for the diagnosis of cardiac a...